Quoting from yesterday's posting:
"The Boettcher Foundation Board of Trustees released the names of the eight early-career scientists selected for the fourth class of Boettcher Investigators in the Webb-Waring Biomedical Research Program. The announcement is made by April Giles, President and CEO of the Colorado BioScience Association (CBSA), who said 'Our association commends Boettcher Foundation for its ongoing commitment to this stellar program that assists early-career investigators in our state to continue their important research.'
Launched in 2010, the Webb-Waring Biomedical Biomedical Research program fills an unmet need in the state by assisting early-career investigators engaged in biomedical sciences to advance their research. Further, the program honors the tradition of Colorado's Webb and Waring families by investing in science that has the possibility of making significant contributions to human health. Boettcher Foundation is a Titanium Sponsor of the CBSA.
Timothy W. Schultz, President and Executive Director of the Boettcher Foundation, said 'Through this program, the Boettcher Foundation has been able to bring resources to an area where funds are currently lacking and where federal and private research programs provide limited support. Early-career investigators quite frequently have a difficult time securing a first opportunity at an independent research effort that will move them out of the laboratory of their mentors and onto their own new and exciting areas of discovery.'"
Link to online.wsj.com